Q3 2013

Filed Nov 18, 2013 · 10-Q · 49 days after period end · 0001213900-13-006648

Q3 2013 · 10-Q

Revenue

$55.69K

N/M vs Q3 2012

Net Income

-$277.18K

N/M vs Q3 2012

EPS Diluted

$0.00

— vs Q3 2012

Gross Profit$14,512N/M

Operating Income

Same quarter

Metric	Q3 2013	Q3 2012	Q3 2011	Q3 2010
Revenue	$55.69K	-$9.93K	$13.20K	$1.79K
Net Income	-$277.18K	-$487.33K	-$346.04K	-$71.39K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR